GOLDMAN SACHS GROUP INC - CERULEAN PHARMA INC ownership

CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 23 filers reported holding CERULEAN PHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CERULEAN PHARMA INC
ValueSharesWeighting
Q4 2016$24,000
-46.7%
33,883
+103.1%
0.00%
Q1 2016$45,000
+25.0%
16,684
+30.5%
0.00%
Q4 2015$36,000
-25.0%
12,780
-2.2%
0.00%
Q3 2015$48,000
-71.1%
13,063
-63.7%
0.00%
Q2 2015$166,000
-64.8%
35,992
-31.2%
0.00%
Q1 2015$471,000
+70.7%
52,284
+17.6%
0.00%
Q4 2014$276,000
+47.6%
44,451
+0.2%
0.00%
Q3 2014$187,000
-32.7%
44,346
-7.6%
0.00%
Q2 2014$278,00047,9800.00%
Other shareholders
CERULEAN PHARMA INC shareholders Q1 2015
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 3,287,529$20,448,00016.18%
Polaris Venture Management Co IV LLC 1,437,441$8,941,0007.04%
Cormorant Asset Management, LP 450,000$2,799,0000.43%
Rock Springs Capital Management LP 550,000$3,421,0000.40%
Deer VII & Co. Ltd. 166,675$1,037,0000.31%
WALL STREET ASSOCIATES 475,000$2,954,0000.28%
Northeast Financial Consultants Inc 20,000$124,0000.06%
PRINCIPAL FINANCIAL GROUP INC 295,200$1,836,0000.00%
FMR LLC 2,431,400$15,123,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 25,014$155,0000.00%
View complete list of CERULEAN PHARMA INC shareholders